Trademark Overview
On Friday, August 29, 2025, a trademark application was filed for CREATE MEDICINES with the United States Patent and Trademark Office. The USPTO has given the CREATE MEDICINES trademark a serial number of 99365272. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, August 29, 2025. This trademark is owned by Myeloid Therapeutics, Inc.. The CREATE MEDICINES trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Biological and medicinal preparations and substances for the prevention and treatment of oncological and immune system related diseases and disorders, and for use with transplantation; biological and medicinal preparations and substances for the prevention and treatment of fibrosis; biological and chemical products for use by clinicians in regenerative medicine for medical purposes, namely, cellular healing therapies and regenerative medicine; biological and medicinal preparations and substances for the prevention and treatment of cancer and infectious diseases; anti-cancer preparations; biological and medicinal preparations and substances for treating genetic diseases
Medical services for the prevention and treatment of cancer and autoimmune and infectious diseases; medical services for the prevention and treatment of fibrosis; medical services in the field of regenerative medicine; medical services for the prevention and treatment of genetic diseases; providing information in the field of cancer, autoimmune and infectious diseases, fibrosis, and genetic diseases and disorders
Providing medical and scientific research information in the fields of cancer, oncology, autoimmune and infectious diseases, and transplantation; medical and scientific research services in the fields of the prevention and treatment of cancer, oncology, autoimmune and infectious diseases, and transplantation; medical and scientific research services in the fields of the prevention and treatment of fibrosis; medical and scientific research services in the field of regenerative medicine; research and development of regenerative medicine; medical and scientific research services in the field of genetic diseases and disorders; providing laboratory research services in the fields of cancer biology, cancer, oncology, autoimmune and infectious diseases, and transplantation
